Pending Approvals-SINOTHERAPEUTICS

    尊龙凯时·(中国)人生就是搏!

    c1_bannerpc-691.jpg c1_bannerph-226.jpg

    Launched Drug

    MESALAMINE Delayed Release Tablet
    meishala.png
    • 【Strength】 1.2g
    • 【Approved Regions】: the United Sate

    【Indication】: induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis

    For more information, please refer to the manua


    POSACONAZOLE delayed-release tablets
    bosha001-102.jpg
    22.jpg
    33.jpg
    bosha004-804.jpg
    • The first generic drug approved in China and the U.S.
    • A new generation of triazole antifungal drugs
    • 【Approved Regions】:China、 the United States、 Australia、Singapore 、 Saudi Arabia、Canada

    【Strength】100mg

    【Indication】Prophylaxis of invasive Aspergillus and Candida Infections

    For more information, please refer to the manua

    URSODEOXYCHOLIC ACID capsules
    xiongquyang001-50.jpg
    • 【Strength】250mg
    • 【Approved Regions】:China

    【Therapeutic field】Digestive liver and gallbladder

    For more information, please refer to the manua

    BUPROPION HYDROCHLORIDE extended-release tablets
    anfeitatong-384.jpg
    anfei.jpg
    • 【Strength】150 mg, 300 mg
    • 【Approved Regions】:China、 the United States

    【INDICATION】• treatment of major depressive disorder (MDD) • prevention of seasonal affective disorder (SAD)

    For more information, please refer to the manua

    PAROXETINE extended-release tablets
    paluo001-513.jpg
    • 【Strength】12.5mg, 25mg
    • 【Approved Regions】:China、 the United States

    【INDICATION】 Paroxetine extended-release tablets are a selective serotonin reuptake inhibitor (SSRI) indicated in adults for the treatment of : • Major Depressive Disorder (MDD) • Panic Disorder (PD) • Social Anxiety Disorder (SAD)

    For more information, please refer to the manua

    SEVELAMER CARBONATE tablets
    siweilamu001-58.png
    • 【Strength】800mg
    • 【Approved Regions】: the United States

    【Indication】 indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis

    For more information, please refer to the manua


    PROPAFENONE HYDROCHLORIDE extended-release capsules
    puluo1.jpg
    • 【Strength】 225 mg, 325 mg, 425 mg
    • 【Approved Regions】: the United States

    【Indication】Propafenone hydrochloride extended-release capsules is an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease.

    For more information, please refer to the manual.

    Pending Approvals

    Shanghai Head Office

    99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China

    Manufacturing Site in Jiangsu

    No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

    Links
    Vastpro
    D-innovation
    qrcode.jpg

    Focus on us

    Copyright © 2014-2022 qhess.com.cn ICP:13048014-1   Powered by Yongsy

    Privacy Legal

    友情链接: